CMG vs STRO · P/E 50, rev $11.93B vs rev $62.0M
Chipotle Mexican Grill Inc (CMG) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Chipotle Mexican Grill Inc (CMG) is a restaurants company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CMG revenue for 2025-12-31 was $11.93B. Net income was $1.54B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. CMG currently screens at market cap $76.00B and trailing P/E 50.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CMG currently screens at market cap $76.00B and trailing P/E 50.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CMG and STRO stock pages for the full models.
Not investment advice.